Madagascar
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Madagascar (MG)
2000 | 75.0 thousand |
2011 | 428.0 thousand |
2024 | 599.3 thousand |
2050 | 1.4 million |
Madagascar is one of the 49 countries and territories in the IDF Africa Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Botswana, Comoros, Eswatini, Lesotho, Malawi, Mozambique, Namibia, South Africa, Zambia and Zimbabwe.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 75.0 | 428.0 | 599.3 | 1,354.5 |
Age-standardised prevalence of diabetes, % | - | 4.7 | 4.6 | 5.0 |
Proportion of people with undiagnosed diabetes, % | - | - | 68.8 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 412.1 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 1,058.9 | 2,451.5 |
Age-standardised prevalence of IFG, % | - | - | 7.3 | 8.5 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 930.8 | 939.0 | 2,193.5 |
Age-standardised prevalence of IGT, % | - | 10.4 | 6.6 | 7.9 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 5,407.0 | 4,785.6 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 3.7 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 54.7 | 117.6 |
Total diabetes-related health expenditure, ID million | - | - | 196.3 | 421.7 |
Diabetes-related health expenditure per person, USD | - | 38.0 | 91.3 | 86.8 |
Diabetes-related health expenditure per person, ID | - | - | 327.6 | 311.4 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 9,971.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 2,701.6 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 7,249.0 | 9,770.3 | 15,694.5 | 30,693.4 |
Population of children and adolescents (0-19 y) | - | - | 15,957,235.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 75.0 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 7,249.0 |
Population of children and adolescents (0-19 y) | - |